Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical and molecular stratification of disease risk in medulloblastoma

1 Aug 2001

Abstract excerpt

The accurate assessment of disease risk among children with medulloblastoma remains a major challenge to the field of paediatric neuro-oncology. In the current study we investigated the capacity of molecular abnormalities to increase the accuracy of disease risk stratification above that afforded by clinical staging alone. 41 primary medulloblastoma tumour samples were analysed for ErbB2 receptor expression using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Neuroblastoma Research and Treatments
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11531256
DOI: 10.1054/bjoc.2001.1987

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical and molecular stratification of disease risk in medulloblastomaPMID 11531256Read ↗

Prognostic classification of pediatric medulloblastoma based on chromosome 17p loss, expression of MYCC and MYCN, and Wnt pathway activationSemantic proximity Read ↗

Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN LociSemantic proximity Read ↗

Classifying the medulloblastoma: insights from morphology and molecular geneticsSemantic proximity Read ↗

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.Semantic proximity Read ↗

Adult and Pediatric Medulloblastomas Are Genetically Distinct and Require Different Algorithms for Molecular Risk StratificationSemantic proximity Read ↗

The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.Semantic proximity Read ↗

Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in NeuroblastomaSemantic proximity Read ↗

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.Semantic proximity Read ↗

Prognostic implications of chromosome 17p deletions in human medulloblastomasSemantic proximity Read ↗

Isochromosome 17q Is a Negative Prognostic Factor in Poor-Risk Childhood Medulloblastoma PatientsSemantic proximity Read ↗

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).Semantic proximity Read ↗

MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.